Mass High Tech

AMAG Pharmaceuticals Announces a Positive CHMP Opinion for the Approval of ...
MarketWatch (press release)
"Iron deficiency anemia can be a debilitating condition for chronic kidney disease patients and appropriate management of this condition can carry positive clinical implications for patients. Therefore, treatment of anemia at all stages of CKD is ...
LONDON, OSAKA, Japan, and LEXINGTON, Massachusetts, April 20, 2012 /PRNewswire/ --PR Newswire UK (press release)
EU committee recommends approval for Amag drugBusinessWeek
AMAG to get $30M milestone paymentMass High Tech

all 30 news articles »